Stay updated on BI456906 Safety & Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.

Latest updates to the BI456906 Safety & Efficacy in NASH Clinical Trial page
- Check7 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1; the study page still displays a 403 error.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content and navigation with an error banner. This indicates the user’s access to the study record is blocked rather than an update to the study data.SummaryDifference17%

- Check35 days agoChange DetectedThe page shows Revision: v3.7.0, replacing the previous Revision: v3.6.6. This reflects a platform version update shown on the page.SummaryDifference0.0%

- Check42 days agoChange DetectedQiryat Krinitzi, Israel, 5265601 was removed and Tel Litwinsky, Israel, 5265601 was added as recruitment sites.SummaryDifference0.1%

- Check49 days agoChange DetectedThe study's location list was updated to add Qiryat Krinitzi, Israel, 5265601 and remove Tel Litwinsky, Israel, 5265601, and the page revision was updated to v3.6.6.SummaryDifference0.1%

Stay in the know with updates to BI456906 Safety & Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.